Kimberly Sue, MD, PhD
she/her/hers
Cards
About
Research
Publications
2024
Drawing on Black and Queer Communities' Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies.
Johnson S, Sue K. Drawing on Black and Queer Communities' Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies. The AMA Journal Of Ethic 2024, 26: e580-586. PMID: 38958427, DOI: 10.1001/amajethics.2024.580.Peer-Reviewed Original ResearchIn Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction)
Dunham K, Hill K, Kazal H, Butner J, Hull I, Sue K, Li L, Doneski K, Dinges B, Rife-Pennington T, Kung S, Thakarar K. In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction). Substance Use & Addiction Journal 2024, 45: 328-336. PMID: 38747578, DOI: 10.1177/29767342241252590.Peer-Reviewed Original ResearchPrevention CenterRates of fatal overdoseSubstance Use and AddictionDrop-in serviceEvidence-based strategiesHarm reduction strategiesMultidisciplinary Education and ResearchUnited StatesLifesaving servicesMedical careAdvocacy effortsIncrease accessPosition statementSocial servicesFatal overdoseEducation and ResearchDrug supplyTrained personnelPWUDPolicy changesFederal levelReduction strategiesInternational dataSterile suppliesServices“It’s Like A Partnership”: Exploring the Primary Care Experiences and Patient-Defined Goals of People Who Use Drugs
Dunham K, Rivas C, Medina Blanco P, Kolod B, Salvati C, Clark K, Sue K, Hagaman A, Weiss J. “It’s Like A Partnership”: Exploring the Primary Care Experiences and Patient-Defined Goals of People Who Use Drugs. Journal Of General Internal Medicine 2024, 1-9. PMID: 38578536, DOI: 10.1007/s11606-024-08743-5.Peer-Reviewed Original ResearchPrimary care goalsPrimary care experiencesPrimary careSemi-structured interviewsCare goalsCare experiencesPatient-defined goalsDesignA qualitative studyOrganizational-level supportPatient health outcomesPrimary care providersPatient-provider collaborationThematic analysis approachHarm reduction settingsBackgroundPrimary carePatient involvementCare outcomesCare teamCare providersHealthcare goalsHealth outcomesHealthcare decisionsDeductive codingQualitative studyHarm reduction
2023
In Support of Community Drug Checking Programs: Position Statement of AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction)
Hill K, Dunham K, Brokos Z, Butner J, Hull I, Sue K, Li L, Thakarar K. In Support of Community Drug Checking Programs: Position Statement of AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction). Substance Use & Addiction Journal 2023, 45: 4-9. PMID: 38258861, DOI: 10.1177/29767342231212787.Peer-Reviewed Original ResearchHarm reduction strategiesPosition statementSerious adverse eventsImportant harm reduction strategyPublic health practitionersAdverse eventsUnregulated drug supplyFatal overdosesHealthcare providersComposition of drugsHealth consequencesHealth practitionersDrugsDrug supplyInsufficient dataDrug checkingUnited StatesClinical considerations for the management of xylazine overdoses and xylazine‐related wounds
Sue K, Hawk K. Clinical considerations for the management of xylazine overdoses and xylazine‐related wounds. Addiction 2023, 119: 606-608. PMID: 37939387, DOI: 10.1111/add.16388.Peer-Reviewed Original ResearchHousing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study
Chayama K, Ng C, Fleming T, Small W, Sue K, McNeil R. Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study. Harm Reduction Journal 2023, 20: 126. PMID: 37679789, PMCID: PMC10483728, DOI: 10.1186/s12954-023-00862-2.Peer-Reviewed Original ResearchConceptsSyringe services programSyringe distribution programsInjecting equipmentSingle room occupancy hotelsDrug-related risksDistribution programHarm reduction measuresHarm reduction supportsLow-threshold accessMethodsBetween JanuaryPWIDDrug useSyringe possessionPeer staffMost participantsIllicit drugsDrugsService programsSyringesSupportive housingParticipantsImproving the Health of People Who Inject Drugs Through COVID-19–Related Policies
Hill K, Thakarar K, Eslinger H, Prosperino L, Sue K. Improving the Health of People Who Inject Drugs Through COVID-19–Related Policies. Public Health Reports 2023, 138: 862-864. PMID: 37610106, PMCID: PMC10576482, DOI: 10.1177/00333549231192468.Commentaries, Editorials and LettersRecognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut
Dowton A, Doernberg M, Heiman E, Barelli P, Golden M, Wang H, Leventhal J, Morford K, Sue K. Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut. Journal Of Addiction Medicine 2023, 17: 739-741. PMID: 37934550, DOI: 10.1097/adm.0000000000001198.Peer-Reviewed Original ResearchConceptsOpioid use disorderUse disordersDrug useCase report presentsIndex of suspicionInjection drug useDrug supplyCare management strategiesHarm reduction strategiesOverdose presentationsCutaneous manifestationsWithdrawal syndromeClinical complicationsCase reportIntravenous useWound carePatientsTreatment of woundsInfectious diseasesChronic woundsXylazineSkin woundsWoundsMore reportingDiagnosisChanging approaches to treating opioid withdrawal in the USA
Hughes M, Edinoff A, Sue K. Changing approaches to treating opioid withdrawal in the USA. The Lancet Psychiatry 2023, 10: 378-380. PMID: 37167986, DOI: 10.1016/s2215-0366(23)00145-1.Commentaries, Editorials and LettersPerspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs
Sue K, Chawarski M, Curry L, McNeil R, Coupet E, Schwartz R, Wilder C, Tsui J, Hawk K, D’Onofrio G, O’Connor P, Fiellin D, Edelman E. Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs. JAMA Network Open 2023, 6: e2312718. PMID: 37163263, PMCID: PMC10173026, DOI: 10.1001/jamanetworkopen.2023.12718.Peer-Reviewed Original ResearchConceptsCommunity-based cliniciansOpioid use disorderEmergency departmentOUD treatmentMedication treatmentSubstance use disorders trainingUrban academic emergency departmentEffectiveness-implementation studyAcademic emergency departmentDisorder treatment settingsPerspectives of cliniciansCommunity-based treatmentCommunity-based treatment programsStaff perspectivesImplementation science frameworkBuprenorphine programTreatment cliniciansPeer navigatorsReferral sitesPromoting ActionMAIN OUTCOMEED staffBuprenorphineFocus groupsUse disorders
Links & Media
News
- July 05, 2024
Weleff Edits New Issue of AMA Journal of Ethics
- May 07, 2024Source: U.S. News and World Report
Almost All Counterfeit Oxycontin Pills Contain Fentanyl
- April 30, 2024
Amid Opioid Overdose Crisis, Yale Program in Addiction Medicine Advises State on Drug Company Settlement Spending
- February 23, 2024
Department of Internal Medicine Promotions and Appointments (February 2024)